145 related articles for article (PubMed ID: 9543636)
1. Growth factor and cytokine modulation of trabecular meshwork matrix metalloproteinase and TIMP expression.
Alexander JP; Samples JR; Acott TS
Curr Eye Res; 1998 Mar; 17(3):276-85. PubMed ID: 9543636
[TBL] [Abstract][Full Text] [Related]
2. Expression of matrix metalloproteinases and inhibitor by human trabecular meshwork.
Alexander JP; Samples JR; Van Buskirk EM; Acott TS
Invest Ophthalmol Vis Sci; 1991 Jan; 32(1):172-80. PubMed ID: 1846130
[TBL] [Abstract][Full Text] [Related]
3. Regulation of the levels of human trabecular matrix metalloproteinases and inhibitor by interleukin-1 and dexamethasone.
Samples JR; Alexander JP; Acott TS
Invest Ophthalmol Vis Sci; 1993 Nov; 34(12):3386-95. PubMed ID: 8225873
[TBL] [Abstract][Full Text] [Related]
4. Effects of mechanical stretching on trabecular matrix metalloproteinases.
Bradley JM; Kelley MJ; Zhu X; Anderssohn AM; Alexander JP; Acott TS
Invest Ophthalmol Vis Sci; 2001 Jun; 42(7):1505-13. PubMed ID: 11381054
[TBL] [Abstract][Full Text] [Related]
5. Effect of matrix metalloproteinases activity on outflow in perfused human organ culture.
Bradley JM; Vranka J; Colvis CM; Conger DM; Alexander JP; Fisk AS; Samples JR; Acott TS
Invest Ophthalmol Vis Sci; 1998 Dec; 39(13):2649-58. PubMed ID: 9856774
[TBL] [Abstract][Full Text] [Related]
6. Matrix metalloproteinases and tissue inhibitors of metalloproteinases in human gliomas.
Nakano A; Tani E; Miyazaki K; Yamamoto Y; Furuyama J
J Neurosurg; 1995 Aug; 83(2):298-307. PubMed ID: 7616276
[TBL] [Abstract][Full Text] [Related]
7. Effect of phorbol ester and cytokines on matrix metalloproteinase and tissue inhibitor of metalloproteinase expression in tumor and normal cell lines.
Mackay AR; Ballin M; Pelina MD; Farina AR; Nason AM; Hartzler JL; Thorgeirsson UP
Invasion Metastasis; 1992; 12(3-4):168-84. PubMed ID: 1284126
[TBL] [Abstract][Full Text] [Related]
8. Involvement of protein kinase C in TNFalpha regulation of trabecular matrix metalloproteinases and TIMPs.
Alexander JP; Acott TS
Invest Ophthalmol Vis Sci; 2001 Nov; 42(12):2831-8. PubMed ID: 11687525
[TBL] [Abstract][Full Text] [Related]
9. Expression of matrix metalloproteinases and inhibitor by human retinal pigment epithelium.
Alexander JP; Bradley JM; Gabourel JD; Acott TS
Invest Ophthalmol Vis Sci; 1990 Dec; 31(12):2520-8. PubMed ID: 2176183
[TBL] [Abstract][Full Text] [Related]
10. Differential regulation of the expression of matrix metalloproteinases and tissue inhibitors of metalloproteinases by cytokines and growth factors in bovine endometrial stromal cells and trophoblast cell line BT-1 in vitro.
Hirata M; Sato T; Tsumagari M; Shimada A; Nakano H; Hashizume K; Ito A
Biol Reprod; 2003 Apr; 68(4):1276-81. PubMed ID: 12606436
[TBL] [Abstract][Full Text] [Related]
11. p38 MAP kinase pathway and stromelysin regulation in trabecular meshwork cells.
Kelley MJ; Rose A; Song K; Lystrup B; Samples JW; Acott TS
Invest Ophthalmol Vis Sci; 2007 Jul; 48(7):3126-37. PubMed ID: 17591882
[TBL] [Abstract][Full Text] [Related]
12. Increased matrix metalloproteinases in the aqueous humor of patients and experimental animals with uveitis.
Di Girolamo N; Verma MJ; McCluskey PJ; Lloyd A; Wakefield D
Curr Eye Res; 1996 Oct; 15(10):1060-8. PubMed ID: 8921246
[TBL] [Abstract][Full Text] [Related]
13. Involvement of the Erk-MAP kinase pathway in TNFalpha regulation of trabecular matrix metalloproteinases and TIMPs.
Alexander JP; Acott TS
Invest Ophthalmol Vis Sci; 2003 Jan; 44(1):164-9. PubMed ID: 12506070
[TBL] [Abstract][Full Text] [Related]
14. Divergent regulation by growth factors and cytokines of 95 kDa and 72 kDa gelatinases and tissue inhibitors or metalloproteinases-1, -2, and -3 in rabbit aortic smooth muscle cells.
Fabunmi RP; Baker AH; Murray EJ; Booth RF; Newby AC
Biochem J; 1996 Apr; 315 ( Pt 1)(Pt 1):335-42. PubMed ID: 8670128
[TBL] [Abstract][Full Text] [Related]
15. Expression of matrix metalloproteinases and their inhibitors in human trabecular meshwork cells.
Pang IH; Hellberg PE; Fleenor DL; Jacobson N; Clark AF
Invest Ophthalmol Vis Sci; 2003 Aug; 44(8):3485-93. PubMed ID: 12882798
[TBL] [Abstract][Full Text] [Related]
16. Human dermal microvascular endothelial cells produce matrix metalloproteinases in response to angiogenic factors and migration.
Cornelius LA; Nehring LC; Roby JD; Parks WC; Welgus HG
J Invest Dermatol; 1995 Aug; 105(2):170-6. PubMed ID: 7543547
[TBL] [Abstract][Full Text] [Related]
17. Cultured human trabecular meshwork cells express functional growth factor receptors.
Wordinger RJ; Clark AF; Agarwal R; Lambert W; McNatt L; Wilson SE; Qu Z; Fung BK
Invest Ophthalmol Vis Sci; 1998 Aug; 39(9):1575-89. PubMed ID: 9699547
[TBL] [Abstract][Full Text] [Related]
18. Early changes in matrix metalloproteinases and inhibitors after in vitro laser treatment to the trabecular meshwork.
Parshley DE; Bradley JM; Samples JR; Van Buskirk EM; Acott TS
Curr Eye Res; 1995 Jul; 14(7):537-44. PubMed ID: 7587299
[TBL] [Abstract][Full Text] [Related]
19. Trabecular cell expression of fibronectin and MMP-3 is modulated by aqueous humor growth factors.
Tripathi BJ; Tripathi RC; Chen J; Gotsis S; Li J
Exp Eye Res; 2004 Mar; 78(3):653-60. PubMed ID: 15106945
[TBL] [Abstract][Full Text] [Related]
20. Corticosteroid treatment and trabecular meshwork proteases in cell and organ culture supernatants.
Snyder RW; Stamer WD; Kramer TR; Seftor RE
Exp Eye Res; 1993 Oct; 57(4):461-8. PubMed ID: 8282032
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
